Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0212-2026

BIOMET ZipTight, Acute AC Joint Implant, Single Ziploop Recall

BIOMET ZipTight, Acute AC Joint Implant, Single Ziploop , Model/Catalog Number: 904834; Fixation System for AC Joint Repair

FDA recall Class II

Ongoing

FDA lists this Class II recall for BIOMET ZipTight, Acute AC Joint Implant, Single Ziploop. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0212-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Sep 23, 2025
FDA report date
Oct 29, 2025
Quantity in commerce
98 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

BIOMET ZipTight, Acute AC Joint Implant, Single Ziploop , Model/Catalog Number: 904834; Fixation System for AC Joint Repair

Affected model & UDI checker

Search the exact identifiers published for Z-0212-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
904834BIOMET ZipTight, Acute AC Joint Implant, Single ZiploopCheck source noticeNot specified
Not specifiedBIOMET ZipTight, Acute AC Joint Implant, Single ZiploopCheck source notice00880304478404
FDA code information

UDI-DI (01)00880304478404(17)290130(10)0002587666; Lot Number 0002587666

View the original FDA recall notice

Why was this product recalled?

There is a potential for a missing slotted button assembly in one lot of ZipTight, Acute AC Joint Implant, Single Ziploop

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did BIOMET, INC. take?

Zimmer Biomet issued an URGENT MEDICAL DEVICE RECALL notice to its consignees (Distributors and Risk Managers-separate notices) on 09/23/2025 via FedEx 2nd day. The notice explained the issue, risk, and requested the consignee (distributors) identify and quarantine the affected product and immediately return all affected product from your distributorship and from affected hospitals within your territory, review the list of hospitals included with the email notification sent to your facility, which includes a list of hospitals that have already been notified of this recall, Identify whether there are any additional hospitals that Zimmer Biomet has not notified and list these accounts on the Additional Accounts form. Please provide the form in Excel format, and If there are no additional accounts to notify, please indicate that there are no additional accounts, or indicate None or NA on the form. Risk Managers were requested to quarantine all affected product pending collection from the distributor, and to provide a copy of the notice to those to whom the product was distributed. For questions or concerns after reviewing this notice, please call customer service at 574-371-3071 between 8:00 am and 5:00pm EST, Monday through Friday. Calls received outside of call center operating hours will receive a voicemail prompt or be transferred to an on-call representative in the event of an emergency. Alternatively, your questions may be emailed to CorporateQuality.PostMarket@zimmerbiomet.com.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology